Epithelial ovarian cancer: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Replaced content with "__NOTOC__ {{CMG}}{{AE}}{{HMHJ}}")
Line 1: Line 1:
__NOTOC__
__NOTOC__
[[File:Downstream effect of p53 mutation..jpg|alt=Downstream effect of p53 mutation|center|frame|Downstream effect of p53 mutation.<ref name="pmid26082798">{{cite journal |vauthors=Pantziarka P |title=Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche |journal=Ecancermedicalscience |volume=9 |issue= |pages=541 |date=2015 |pmid=26082798 |pmc=4462886 |doi=10.3332/ecancer.2015.541 |url=}}</ref>]]
 
{{Epithelial ovarian cancer}}
{{CMG}}{{AE}}{{HMHJ}}
{{CMG}}{{AE}}{{HMHJ}}

Revision as of 14:13, 26 February 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Hannan Javed, M.D.[2]